UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.uhhospitals.org

Clinical Trials

Postpartum Vaginal Estrogen for Breastfeeding Patients

Phase 4

Not yet recruiting

Conditions: Breastfeeding
Postpartum Sexual Dysfunction
Vaginal Atrophy

Interventions: Device: Vaginal Moisturizer
Drug: Estradiol

First Posted Date: 2022-07-14

Last Posted Date: 2024-12-06

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 100

Registration Number: NCT05457972

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

Phase 4

Completed

Conditions: Eosinophilic Esophagitis

Interventions: Drug: Fluticasone Propionate
Drug: Budesonide

First Posted Date: 2022-07-06

Last Posted Date: 2024-11-07

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 23

Registration Number: NCT05444543

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Pilot Evaluation of FAMCOPE-ICU (Family Coping and Emotion Regulation Tool in the ICU)

Not Applicable

Completed

Conditions: Emotion Regulation
Coping Skills

Interventions: Behavioral: FAMCOPE-ICU

First Posted Date: 2022-06-07

Last Posted Date: 2023-07-28

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 49

Registration Number: NCT05408468

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

Not Applicable

Active, not recruiting

Conditions: Post-acute COVID-19 Syndrome

Interventions: Dietary Supplement: Vitamin K2 (MK-7)
Dietary Supplement: Vitamin D3

First Posted Date: 2022-05-02

Last Posted Date: 2023-10-06

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 150

Registration Number: NCT05356936

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

Phase 4

Recruiting

Conditions: Pregnancy Preterm
Pregnancy Prom
PROM, Preterm (Pregnancy)
PROM (Pregnancy)
Premat Rupture Membranes Preterm Unspec to Length of Time Between Rupture/Labor
Premature Birth

Interventions: Drug: Azithromycin Pill
Drug: Amoxicillin Pill

First Posted Date: 2022-04-26

Last Posted Date: 2024-03-15

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 88

Registration Number: NCT05345457

Locations: 🇺🇸
MetroHealth, Cleveland, Ohio, United States
🇺🇸
University Hospitals, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings

Not Applicable

Completed

Conditions: Covid19
Diabetes Mellitus

Interventions: Device: continuous glucose monitoring

First Posted Date: 2022-04-25

Last Posted Date: 2023-02-10

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 9

Registration Number: NCT05343624

Locations: 🇺🇸
University Hospitals Cleveland Medical center, Cleveland, Ohio, United States

Impact of Surgical Theater's Patient Engagement

Not Applicable

Terminated

Conditions: Cervical Spine Surgeries
Lumbar Spine Surgeries

Interventions: Device: Surgical Theater

First Posted Date: 2022-04-19

Last Posted Date: 2023-02-13

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 7

Registration Number: NCT05334212

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸
University Hospitals at Southwest General Medical Center, Middleburg Heights, Ohio, United States

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

Phase 4

Terminated

Conditions: Alopecia Areata

Interventions: Combination Product: MedJet Device with intralesional triamcinolone

First Posted Date: 2022-03-14

Last Posted Date: 2024-01-31

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 3

Registration Number: NCT05278858

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

Phase 4

Recruiting

Conditions: Psoriasis

Interventions: Drug: Ustekinumab

First Posted Date: 2022-03-08

Last Posted Date: 2024-02-14

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 56

Registration Number: NCT05270733

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Immunological Responses of COVID-19 Vaccination

Completed

Conditions: Cancer; Chemotherapy

Interventions: Other: COVID antibody titers in the blood

First Posted Date: 2022-02-14

Last Posted Date: 2023-02-21

Lead Sponsor: University Hospitals Cleveland Medical Center

Target Recruit Count: 42

Registration Number: NCT05238467

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy